These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. FDA approves over the counter sale of naloxone to reverse drug overdoses. Tanne JH BMJ; 2023 Mar; 380():749. PubMed ID: 36997192 [No Abstract] [Full Text] [Related]
7. Australia reschedules naloxone for opioid overdose. Lenton SR; Dietze PM; Jauncey M Med J Aust; 2016 Mar; 204(4):146-7. PubMed ID: 26937664 [No Abstract] [Full Text] [Related]
8. In brief: Higher-dose naloxone nasal spray (Kloxxado) for opioid overdose. Med Lett Drugs Ther; 2021 Sep; 63(1633):151-152. PubMed ID: 34550963 [No Abstract] [Full Text] [Related]
9. Naloxone Over the Counter: Increasing Opportunities and Challenges for Health Providers. Ardeljan AD; Fiedler B; Fiedler L; Luck GR; Maki DG; Clayton L; Hennekens CH; Ferris A Am J Med; 2023 Jun; 136(6):504-506. PubMed ID: 36750143 [No Abstract] [Full Text] [Related]
10. Equipping an urban hospital police and security team with Narcan. Driscoli J; Michelman B J Healthc Prot Manage; 2016 Oct; 32(2):1-4. PubMed ID: 29638270 [TBL] [Abstract][Full Text] [Related]
11. Nonprescription naloxone: pros and cons. S Bastianelli KM; Orr KK J Am Pharm Assoc (2003); 2014; 54(4):328-9. PubMed ID: 25063253 [No Abstract] [Full Text] [Related]
12. An increase in per-patient naloxone requirements in an opioid epidemic. Birmingham LE; Nielson JA Am J Emerg Med; 2017 Dec; 35(12):1958-1959. PubMed ID: 28633907 [No Abstract] [Full Text] [Related]
13. Intravenous use of intranasal naloxone: A case of overdose reversal. Das S; Shah N; Ghadiali M Subst Abus; 2017; 38(1):18-21. PubMed ID: 27925864 [TBL] [Abstract][Full Text] [Related]
14. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations. Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115 [TBL] [Abstract][Full Text] [Related]
15. Overdose reversal. Spencer S Am J Nurs; 2015 Jan; 115(1):13. PubMed ID: 25545511 [No Abstract] [Full Text] [Related]
16. Take-home naloxone in Australia and beyond. Olsen A; Dwyer R; Lenton S Drug Alcohol Rev; 2018 May; 37(4):437-439. PubMed ID: 29744978 [No Abstract] [Full Text] [Related]
17. President's message: Food and Drug Administration approved naloxone and continued use of improvised nasal naloxone: What is a treatment advocate and educator to do? Morrone WR J Addict Dis; 2016; 35(4):339-345. PubMed ID: 27731792 [No Abstract] [Full Text] [Related]
18. FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone. Cohen BR; Mahoney KM; Baro E; Squire C; Beck M; Travis S; Pike-McCrudden A; Izem R; Woodcock J N Engl J Med; 2020 May; 382(22):2129-2136. PubMed ID: 32459923 [TBL] [Abstract][Full Text] [Related]
19. Treatment of opioid overdose: a brief review of naloxone pharmacology and delivery. Hendley TM; Hersh EV; Moore PA; Stahl B; Saraghi M Gen Dent; 2017; 65(3):18-21. PubMed ID: 28475079 [No Abstract] [Full Text] [Related]
20. Over the counter naloxone needed to save lives in the United States. Davis CS; Carr D Prev Med; 2020 Jan; 130():105932. PubMed ID: 31770540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]